GB9301289D0 - Novel composition - Google Patents

Novel composition

Info

Publication number
GB9301289D0
GB9301289D0 GB939301289A GB9301289A GB9301289D0 GB 9301289 D0 GB9301289 D0 GB 9301289D0 GB 939301289 A GB939301289 A GB 939301289A GB 9301289 A GB9301289 A GB 9301289A GB 9301289 D0 GB9301289 D0 GB 9301289D0
Authority
GB
United Kingdom
Prior art keywords
novel composition
novel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939301289A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB939301289A priority Critical patent/GB9301289D0/en
Publication of GB9301289D0 publication Critical patent/GB9301289D0/en
Priority to ZA94398A priority patent/ZA94398B/xx
Priority to CN94191260A priority patent/CN1118141A/zh
Priority to PCT/GB1994/000122 priority patent/WO1994016719A1/en
Priority to NZ259737A priority patent/NZ259737A/en
Priority to EP94904705A priority patent/EP0680332A1/en
Priority to AU58636/94A priority patent/AU5863694A/en
Priority to CA002153797A priority patent/CA2153797A1/en
Priority to JP6516809A priority patent/JPH08505867A/ja
Priority to TW083100558A priority patent/TW241203B/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB939301289A 1993-01-22 1993-01-22 Novel composition Pending GB9301289D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB939301289A GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition
ZA94398A ZA94398B (en) 1993-01-22 1994-01-20 Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation
JP6516809A JPH08505867A (ja) 1993-01-22 1994-01-21 炎症治療用の可溶性補体レセプター１（ｓｃｒ−１）とアミジノフェニルまたはアミジノナフチルエステルの組み合わせ
NZ259737A NZ259737A (en) 1993-01-22 1994-01-21 Complement-inactivating composition comprising soluble cr-1 protein and an amido-(phenyl or naphthyl) ester
PCT/GB1994/000122 WO1994016719A1 (en) 1993-01-22 1994-01-21 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation
CN94191260A CN1118141A (zh) 1993-01-22 1994-01-21 结合使用可溶性补体受体-1(scr1)和脒基苯基或脒基萘基酯治疗炎症
EP94904705A EP0680332A1 (en) 1993-01-22 1994-01-21 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation
AU58636/94A AU5863694A (en) 1993-01-22 1994-01-21 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation
CA002153797A CA2153797A1 (en) 1993-01-22 1994-01-21 Combination of a soluble complement receptor-1(scri) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation
TW083100558A TW241203B (enExample) 1993-01-22 1994-01-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939301289A GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition

Publications (1)

Publication Number Publication Date
GB9301289D0 true GB9301289D0 (en) 1993-03-17

Family

ID=10729169

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939301289A Pending GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition

Country Status (10)

Country Link
EP (1) EP0680332A1 (enExample)
JP (1) JPH08505867A (enExample)
CN (1) CN1118141A (enExample)
AU (1) AU5863694A (enExample)
CA (1) CA2153797A1 (enExample)
GB (1) GB9301289D0 (enExample)
NZ (1) NZ259737A (enExample)
TW (1) TW241203B (enExample)
WO (1) WO1994016719A1 (enExample)
ZA (1) ZA94398B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69431194T2 (de) * 1993-10-21 2002-12-12 G.D. Searle & Co., Chicago Amidino-derivate nützlich als no synthase-hemmer
GB9604518D0 (en) * 1996-03-02 1996-05-01 Smithkline Beecham Plc Novel compounds
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
DE3207033C2 (de) * 1981-02-27 1984-09-13 Torii & Co., Ltd., Tokyo Amidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
EP0560929A1 (en) * 1990-12-06 1993-09-22 T Cell Sciences, Inc. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity

Also Published As

Publication number Publication date
WO1994016719A1 (en) 1994-08-04
AU5863694A (en) 1994-08-15
TW241203B (enExample) 1995-02-21
EP0680332A1 (en) 1995-11-08
NZ259737A (en) 1997-04-24
CN1118141A (zh) 1996-03-06
ZA94398B (en) 1994-11-15
JPH08505867A (ja) 1996-06-25
CA2153797A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
GR3036591T3 (en) Novel composition
GB9318841D0 (en) Composition
ZA942052B (en) Tricritical point composition
GB9302130D0 (en) Cleasing composition
GB9310700D0 (en) Novel composition
GB9203474D0 (en) Novel composition
GB9313274D0 (en) Composition
GB2281914B (en) Composition
GB9324409D0 (en) Novel composition
GB2282385B (en) Composition
GB9301289D0 (en) Novel composition
ZA946967B (en) Lyophillisate composition
GB9320370D0 (en) Frit-containing composition
GB9321876D0 (en) Novel composition
GB2271999B (en) Novel composition
GB9320598D0 (en) Composition
GB9322288D0 (en) Novel composition
GB9308170D0 (en) Novel composition
GB9301136D0 (en) Novel composition
SI0727979T1 (en) Novel composition
GB9317222D0 (en) Composition
GB9318548D0 (en) Composition
GB9319818D0 (en) Composition
GB9317257D0 (en) Composition
GB9307790D0 (en) Composition